Status:
UNKNOWN
Houston "Breathe Easy" Healthy Homes-Based Model for Multifamily Rental Communities
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
Harris County Hospital District
The University of Texas Health Science Center, Houston
Conditions:
Asthma
Respiratory Tract Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary purpose of this pragmatic randomized clinical trial is to examine whether the addition of a phone-based multicomponent environmental intervention customized for Houston public housing resi...
Detailed Description
This is a pragmatic randomized clinical trial that examines the effectiveness of a clinically informed phone-based environmental intervention for improving asthma control in individuals living in sele...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosis of poorly controlled asthma\*
- Live in one of the selected public housing communities operated by the Houston Housing Authority
- No clear plan to move within the next 6 months
- Working telephone number
- Able to read and speak in English
- Poorly controlled asthma defined as (1) has been diagnosed by a physician as having asthma in the past and currently has asthma; and (2) fulfills one or more of the following criteria of poorly controlled asthma: has had one or more emergency department visits or hospitalizations for asthma in the preceding year; has had asthma symptoms during the daytime at least two days in the past week; has been awoken at night by asthma symptoms one or more nights in the past week; or has used asthma rescue medication at least twice in the past week. These eligibility criteria effectively include two categories of asthma control as defined by the National Asthma Education and Prevention Program, (NAEPP) Third Expert Panel (EPR3) on the Diagnosis and Management of Asthma: "not well controlled" and "very poorly controlled" asthma.
Exclusion
- Severe co-morbid conditions--such as a poorly controlled psychiatric illness or a condition requiring intense medical treatment--that could reasonably be expected to (1) confound the effects of this study's intervention or (2) make it unlikely that a participant could follow the treatment plan.
- A concurrent pulmonary study that could reasonably be expected to confound the effects of the intervention.
Key Trial Info
Start Date :
August 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05345080
Start Date
August 27 2020
End Date
June 30 2022
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030